OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: pfizer

Investors Taking Notice of Potential in Acura Pharmaceuticals, Inc. (NASDAQ: ACUR)

After closing Wednesday’s trading session at 1.42 on light volume shares of Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) have spiked considerably on Thursday, climbing as high as 2.60 with more than 1 million shares exchanging hands by early afternoon. That 2.60 … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , | Leave a comment

Can Pain Therapeutics Inc. (NASDAQ: PTIE) Overcome Setback Related to Remoxy?

Shares of Pain Therapeutics Inc. (NASDAQ: PTIE) continue to take a beating following news that their lead drug candidate Remoxy will be subjected to further tests before Pfizer agrees to seek FDA approval for the pain medication. Just yesterday shares … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , , | Leave a comment

Investors Interested in United Management Group, Inc.(PINKSHEETS: UYMG) Have More Questions than Answers

It doesn’t take a lot of digging before investors uncover a number of questions concerning the operations of Unity Management Group, Inc. (PINKSHEETS: UYMG). While the company announced on Wednesday that their subsidiary, Metropolitan Computing Corporation (MCC), had sold its … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

Alexza Pharmaceuticals (NASDAQ: ALXA) Gaining Momentum on FDA Approval Recommendation Regarding ADASUVE

Following news that Alexza Pharmaceuticals (NASDAQ: ALXA) received recommendation for FDA approval from the Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food and Drug Administration (FDA) relating to their schizophrenia and bipolar mania treatment ADASUVE shares in the pharmaceutical … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , , , , | Leave a comment

Icagen, Inc. (NASDAQ: ICGN) Could See Bad Memories Erased with Pfizer, Inc. (NYSE: PFE) “Strategic Transaction”

Nine months ago Icagen, Inc. (NASDAQ: ICGN) announced they had completed a one-for-eight reverse stock split that managed to push shares from 0.13 to 1.01 and put them back in compliance with NASDAQ listing requirements. Times have changed significantly for … Continue reading

Posted in Articles, NASDAQ, Penny Stocks | Tagged , , , , , , , , , , , | Leave a comment

NYSE Companies Hitting New 52-Week Highs on Monday: PFE, TSO, LZ, STD, POT

A number of companies trading on the NYSE managed to set new 52-week highs on Monday including Pfizer (PFE), Tesoro Petroleum Corp (TSO), Lubrizol Corp. (LZ), Banco Santander S.A. (STD), and Potash Corporation (POT).

Posted in News | Tagged , , , , , , , , , , , , | Leave a comment

Despite Milestone Payment from Pfizer Future for Icagen, Inc. Remains Uncertain

News of a $1 million milestone payment from Pfizer (NYSE: PFE) earlier this week sent shares in Icagen, Inc. (NASDAQ: ICGN) skyrocketing to a 52-week high of 2.63 but the push north quickly halted and before long shares tumbled below … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , , , , | Leave a comment

Healthcare Stocks Showing Signs of Life: ICGN, APCVZ, RPRX, SCR, BASI

While Healthcare Stocks took a hit on Tuesday, dropping 0.97%, there were several companies that proved to have plenty of life with Icagen, Inc. (NASDAQ: ICGN) earning the top grade as shares jumped 78.69% on the day to close at … Continue reading

Posted in NASDAQ, News | Tagged , , , , , , , , , , , , , , , , | Leave a comment